27/05/2026
28/05/2026
Health Revolution Congress is one of Europe’s leading digital health events. Its agenda focuses on how technology, artificial intelligence and new collaboration models can improve healthcare delivery, accelerate clinical innovation and address today’s key challenges in health.
Recinte Modernista de Sant Pau
Barcelona
Health Revolution Congress (HRC) 2026 took place on 27 and 28 May at the Recinte Modernista de Sant Pau in Barcelona, consolidating its position as one of Europe’s leading digital health events. Organised by Barcelona Health Hub, the event brought together startups, corporates, hospitals, investment funds and healthcare professionals to discuss the challenges and opportunities transforming the healthcare model.
This edition’s programme was strongly marked by the real-world application of artificial intelligence in clinical, care and operational settings. AI appeared in connection with increasingly concrete use cases: diagnostic support, clinical efficiency, process automation, patient monitoring, treatment personalisation, clinical trials and drug development. The congress also included spaces designed to foster collaboration between corporates and startups, such as the HRC Open Innovation Challenge, created to connect specific technological challenges with innovative solutions from the ecosystem.
Members of the GCO Ventures team attended HRC 2026 together with the team from Aurela, one of the ventures in our portfolio. This joint presence allowed us to bring together two complementary perspectives: that of GCO Ventures as a platform that promotes, builds and supports new businesses, and that of a team working directly on one of today’s major challenges in healthcare.One of the most relevant aspects of the event was seeing how digital health is entering a phase that is less focused on promise and more oriented towards real implementation. It is no longer enough to present a promising technology: evidence, validation, integration into complex systems, data security and the ability to generate impact for patients, professionals and organisations are becoming increasingly important.
At GCO Ventures, we see particular potential in solutions that combine prevention, personalisation and efficiency. Aurela brings this vision to life in the field of mental health, where technology is not a magic solution, but can be a highly valuable lever to expand access, improve adherence, scale preventive wellbeing and better support people before problems become more severe.
In healthcare, technology only scales when it generates trust, evidence and real impact. This is a principle we apply both in our startup creation and investment activity and in the way we support ventures such as Aurela. It is also part of how these teams evolve their solutions based on the market, evidence and people’s real needs.